The biotech told investors “it is likely the primary efficacy endpoint was not achieved" in a phase 2 trial of a would-be rival to AbbVie's Creon.

First Wave Biopharma has inked a deal for Rho to run a Phase 2 trial for the biopharma’s treatment for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis.

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Wave Neuroscience announced today the receipt of a generous $1.5 million grant from the Engelstad Foundation that will support Wave Neuroscience’s Phase ...

Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the stage for a new therapeutic option for patients with the rare disease.

(RTTNews) - Wave Life Sciences (WVE), a clinical-stage biotechnology company, on Thursday initiated the Phase 1 INLIGHT clinical trial for WVE-007, a novel, long-acting RNA-based therapeutic aimed ...

--First Wave BioPharma, Inc.,,, a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, today announced that ...

California power grid managers are warning of possible rolling blackouts as temperatures from the already-oppressive heat wave spike to even great heights on Monday and Tuesday.

Toshiba’s Hall sensorless sine-wave drive three-phase brushless DC motor control pre-driver IC helps reduce vibration and noise of high-speed motors.